Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Taysha Gene Therapies, Inc. - Common Stock
(NQ:
TSHA
)
6.200
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Taysha Gene Therapies, Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Taysha Gene Therapies to Release First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 11
May 04, 2021
From
Taysha Gene Therapies, Inc.
Via
Business Wire
Taysha Gene Therapies Announces New Data on Multiple Preclinical Programs and Upcoming R&D Day
April 14, 2021
From
Taysha Gene Therapies, Inc.
Via
Business Wire
What's Going On With MOSY Stock And TSHA Stock?
↗
April 12, 2021
MoSys Inc. (NASDAQ: MOSY) shares are trading higher after the company announced it has expanded its patent portfolio through the purchase of five patents in the area of search and...
Via
Benzinga
Topics
Intellectual Property
Mid-Afternoon Market Update: Dow Falls Over 100 Points; Canaan Shares Tumble After Q4 Results
↗
April 12, 2021
Toward the end of trading Monday, the Dow traded down 0.32% to 33,691.74while the NASDAQ fell 0.52% to 13,828.15. The S&P also fell, dropping 0.20% to 4,120.43. The U.S. has...
Via
Benzinga
Topics
Stocks
Why Taysha Gene Therapies's Stock is Trading Higher Today
↗
April 12, 2021
The Price And Volume Action In Taysha Gene Therapies's Stock Today Taysha Gene Therapies's (NASDAQ:
Via
Benzinga
55 Biggest Movers From Yesterday
↗
April 13, 2021
Gainers Celcuity Inc. (NASDAQ: CELC) jumped 29.4% to settle at $27.94. Celcuity shares climbed 51% on Friday after the company announced a worldwide licensing agreement with...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
April 12, 2021
Gainers 180 Life Sciences (NASDAQ:ATNF) shares increased by 27.31% to $12.4 during Monday's regular session. Trading volume for 180 Life Sciences's stock is 29.3...
Via
Benzinga
Mid-Day Market Update: Crude Oil Rises 2%; iRhythm Technologies Shares Plummet
↗
April 12, 2021
Midway through trading Monday, the Dow traded down 0.22% to 33,725.47 while the NASDAQ fell 0.55% to 13,823.65. The S&P also fell, dropping 0.21% to 4,120.15. The U.S. has the...
Via
Benzinga
Topics
Stocks
42 Stocks Moving In Monday's Mid-Day Session
↗
April 12, 2021
Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 44.8% to $8.05 after the company's 13D filing showed that Modell's Sporting Goods had reported a stake...
Via
Benzinga
Taysha Gene Therapies Stock Is Trading Higher After Buying Rights To New Gene Therapy Candidate For Neurodegenerative Disease
↗
April 12, 2021
Taysha Gene Therapies Inc (NASDAQ: TSHA) has unveiled a deal for global rights to the AAV9 gene therapy program, now known as TSHA-120, to treat giant axonal...
Via
Benzinga
Taysha Gene Therapies Acquires Exclusive Worldwide Rights to Clinical-Stage AAV9 Gene Therapy Program, Now Known as TSHA-120, for the Treatment of Giant Axonal Neuropathy, a Rare and Severe Neurodegenerative Disease
April 12, 2021
From
Taysha Gene Therapies, Inc.
Via
Business Wire
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today